Dapagliflozin


( Last Updated : October 23, 2018)
Generic Name:
Dapagliflozin
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus, type 2
Manufacturer:
AstraZeneca Canada Inc.
Call for patient/clinician input open:
Brand Name:
Forxiga
Project Line:
Reimbursement Review
Project Number:
SR0445-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC

Details


Submission Type:
Initial
Indications:
Diabetes mellitus, type 2
Recommendation Type:
Do not list
Final Recommendation: